A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2011
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	CA2505538C Papaya puree and its use
10/25/2011	CA2460834C Matrix metalloproteinase inhibitor
10/20/2011	WO2011129716A1 Means for the prophylaxis and treatment of acute and chronic pancreatitis
10/20/2011	WO2011129495A1 Method for extracting an anticaries substance from licorice
10/20/2011	WO2011128429A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of crohn's disease
10/20/2011	WO2011127625A1 Method for regulating microrna content in organisms and uses thereof
10/20/2011	WO2011127499A1 Animal feed additive having an antimicrobial and growth-promoting effect
10/20/2011	WO2011127496A1 Animal feed additive having an antimicrobial and growth-promoting effect
10/20/2011	US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011	US20110257405 Process for producing crystal
10/20/2011	US20110257271 Derivatives of dimethylcurcumin
10/20/2011	US20110257269 Preventive and/or therapeutic agent for inflammatory bowel diseases
10/20/2011	US20110257238 Heteroaryl Dihydroindolones as Kinase Inhibitors
10/20/2011	US20110257236 Solid solution of valine, isoleucine, leucine and its manufacturing method
10/20/2011	US20110257233 Benzoisothiazolones as inhibitors of phosphomannose isomerase
10/20/2011	US20110257230 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257223 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
10/20/2011	US20110257222 Compounds and methods for the treatment of pain and other diseases
10/20/2011	US20110257210 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257208 Compounds useful as faah modulators and uses thereof
10/20/2011	US20110257194 Substituted oxindol derivatives and medicaments containing the same
10/20/2011	US20110257182 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011	US20110257179 Novel thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011	US20110257178 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/20/2011	US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
10/20/2011	US20110257170 4-morpholino-pyrido[3,2-d]pyrimidines
10/20/2011	US20110257164 Dipeptidyl peptidase iv inhibitors
10/20/2011	US20110257161 Novel diaza-bicyclononyl-phenyl derivatives and their medical use
10/20/2011	US20110257153 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/20/2011	US20110257139 Treatment of diarrhoea
10/20/2011	US20110257127 A2b adenosine receptor antagonists
10/20/2011	US20110257126 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
10/20/2011	US20110257113 Method for Inducing a Trif-Bias
10/20/2011	US20110257105 Synthetic peptide amides and dimers thereof
10/20/2011	US20110257095 Pharmaceutical compositions and related methods of delivery
10/20/2011	US20110257094 Anti periodontitis-causing microorganism agent and medical or dental materials using the same
10/20/2011	US20110257086 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes
10/20/2011	US20110257085 Crystal Forms of Saxagliptin and Processes for Preparing Same
10/20/2011	US20110257084 Exendin derivative linked biotin, method for the preparation thereof and pharmaceutical composition comprising the same
10/20/2011	US20110256625 Liver Engrafting Cells, Assays, and Uses Thereof
10/20/2011	US20110256246 Essential oil of kunzea ambigua and methods of use
10/20/2011	US20110256245 Methods and compositions of cannabis extracts
10/20/2011	US20110256230 Water insoluble polymer: indigestible water-soluble polysaccharide film coatings for colon targeting
10/20/2011	US20110256220 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
10/20/2011	US20110256218 Controlled release compositions comprising meclizine or related piperazine derivatives
10/20/2011	US20110256217 Pulsatile release compositions and methods for enhanced intestinal drug absorption
10/20/2011	US20110256216 Probiotic Confection and Lipid Compositions
10/20/2011	US20110256186 biomaterial based on wharton's jelly from the human umbilical cord
10/20/2011	US20110256183 Hydrogels with network defects enhanced by nanoparticle incorporation
10/20/2011	US20110256161 Methods for enhancing immune response
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256149 Antibody formulation
10/20/2011	US20110256132 Myostatin binding proteins
10/20/2011	US20110256131 BLOCKERS OF LIGHT, LTalpha1beta2 AND LTalpha2beta1 OR ITS RECEPTOR LTbetaR FOR THE PREVENTION AND TREATMENT OF CHRONIC HEPATITIS AND OTHER LIVER DISEASES
10/20/2011	US20110256130 Methods of treating inflammatory disorders
10/20/2011	US20110256126 IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
10/20/2011	US20110256123 Methods and uses of leptin in immune modulation and hepatocellular carcinoma
10/20/2011	US20110256098 Immunotherapy for chronic hepatitis c virus infection
10/20/2011	US20110256073 Formulations for treating and/or preventing Black-Line Stains
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	US20110253133 Methods and compositions for administration of oxybutynin
10/20/2011	CA2796248A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of crohn's disease
10/19/2011	EP2377932A1 ANTI-Siglec-15 ANTIBODY
10/19/2011	EP2377883A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease
10/19/2011	EP2377875A1 Antioxidant
10/19/2011	EP2377874A1 Antioxidant
10/19/2011	EP2377545A1 Antibacterial agent for periodontal disease-causing bacteria, and medical or dental material using same
10/19/2011	EP2376519A1 Tgr5 modulators and method of use thereof
10/19/2011	EP2376075A2 Nasal formulations of metoclopramide
10/19/2011	EP2363142A9 Elastase for opening obstructed biological conduits
10/19/2011	EP2221377B1 Oligonucleotide compositions with enhanced efficiency
10/19/2011	EP2162125B1 Composition for rectal administration combined with an oral alpha-lipoic acid composition for the treatment of inflammatory bowel disease
10/19/2011	EP2101809B1 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction
10/19/2011	EP1967195B1 Antacid
10/19/2011	EP1923387B1 Acylguanidine derivative or salt thereof
10/19/2011	EP1871380B1 Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
10/19/2011	EP1499613B1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/19/2011	EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011	EP1341524B1 Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	DE202011004860U1 Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Prophylaxe von als negativ empfundener Geruchsbelästigung von Stoffwechselprodukten über Mund- und/oder Nasenhöhle und/oder Urin und/oder Stuhl Drugs, or dietary supplements for the treatment and / or prophylaxis of perceived negative odor of metabolites through oral and / or nasal cavity and / or urine and / or stool
10/19/2011	CN102224242A Novel gene cluster
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102224141A Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
10/19/2011	CN102223884A Solid pharmaceutical composition
10/19/2011	CN102221590A Method for simultaneously determining multi-index ingredients of Simotang preparation and establishing fingerprint chromatogram thereof
10/19/2011	CN102220216A Acanthopanax sessiliflorus white spirit and brewing method thereof
10/19/2011	CN102220215A Health-care wine
10/19/2011	CN102219855A High-affinity anti-EGFR (epidermal growth factor receptor) monoclonal antibody
10/19/2011	CN102219850A New long-acting GLP-1 (glucagonlike peptide-1) compounds
10/19/2011	CN102219745A 2-aryl substituted benzimidazole derivatives, as well as preparation method and application thereof
10/19/2011	CN102219725A Benzohetercyclic compound as well as preparation method and applications thereof
10/19/2011	CN102219720A Novel selenic acid biological material with anti-aging function
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218132A Medicinal composition for treating nasal bleeding
10/19/2011	CN102218128A Health-care medicinal tea and its preparation method
10/19/2011	CN102218123A Quality control method for liver soothing and qi regulating pill
10/19/2011	CN102218122A Quality control and detection method for sea dragon and gecko oral liquid
10/19/2011	CN102218114A Traditional Chinese medicine preparation for health care and fatty liver treatment

1 ... 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 ... 1258